Serina Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Serina Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q2 2024.
  • Serina Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 82.1 %, a 855% increase year-over-year.
  • Serina Therapeutics, Inc. annual Return On Equity for 2023 was 45.1 %, a 16.2% decline from 2022.
  • Serina Therapeutics, Inc. annual Return On Equity for 2022 was 53.8 %, a 43.8% decline from 2021.
  • Serina Therapeutics, Inc. annual Return On Equity for 2021 was 95.7 %, a 74.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 82.1 +73.5 +855% Apr 1, 2024 Jun 30, 2024
Q1 2024 83.8 +60 +251% Jan 1, 2024 Mar 31, 2024
Q4 2023 45.1 -8.72 -16.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 16.5 -60 -78.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 8.6 -72.2 -89.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 23.8 -65.2 -73.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 53.8 -41.9 -43.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 76.5 -44 -36.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 80.8 -81.5 -50.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 89.1 -136 -60.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 95.7 -278 -74.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 120 -1.11K -90.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 162 +725 Apr 1, 2021 Jun 30, 2021
Q1 2021 225 +560 Jan 1, 2021 Mar 31, 2021
Q4 2020 373 +568 Oct 1, 2020 Dec 31, 2020
Q3 2020 1.23K +1.39K Jul 1, 2020 Sep 30, 2020
Q2 2020 -562 -435 -343% Apr 1, 2020 Jun 30, 2020
Q1 2020 -335 -234 -231% Jan 1, 2020 Mar 31, 2020
Q4 2019 -195 -120 -160% Oct 1, 2019 Dec 31, 2019
Q3 2019 -165 Jul 1, 2019 Sep 30, 2019
Q2 2019 -127 Apr 1, 2019 Jun 30, 2019
Q1 2019 -101 Jan 1, 2019 Mar 31, 2019
Q4 2018 -74.8 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.